Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Your 2026 Money Reset Starts Now
Personal finance reporter Oyin Adedoyin of The Wall Street Journal breaks down the smartest moves to reset savings, debt, and spending.
Load More